Additionally, metformin may target tumor-initiating stem cell-like glioma cells, also called Glioma Stem Cells (GSC), through AMPK-dependent inhibition of FOXO3 and AKT [18]. The gene discussed is FOXO3; the disease is central nervous system cancer.